Top Markets
Coin of the day
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Kedudukan dalam Saham #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Harga Saham
$0.28545656
Modal Pasaran
$4.50M
Perubahan (1 hari)
5.97%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Acticor Biotech SAS (ALACT)

Kategori

Sejarah harga saham bagi Acticor Biotech SAS (ALACT)
Harga penutupan tertinggi: $0.29 pada 2024-12-01

Harga penutupan terendah: $7.56 pada 2021-11-01
Sejarah harga saham Acticor Biotech SAS dari 2021 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2024 -90.82%
2023 -58.62%
2022 31.92%
2021 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$36.74 -53.49%
DK
$451.49 -11.91%
US
$737.00 9.61%
US
$297.72 51.37%
BE
$94.95 -40.77%
AU